September 26, 2024 September 26, 2024Categories EditorialsRemembering Gerald Green, health equity and cancer research advocateGerald Green served as an advocate with the ECOG-ACRIN Cancer Research Group for over six years
September 26, 2024 September 26, 2024Categories New TrialsNow Enrolling: The EA7222 clinical trial is testing a new treatment for patients with advanced soft tissue sarcomaThis study is for patients who have a type of soft tissue sarcoma, called undifferentiated pleomorphic sarcoma, that has spread to other areas in the body
September 26, 2024 September 26, 2024Categories Ongoing TrialsVideo: An advocate and a physician discuss the SOAR study for patients with advanced kidney cancerWatch cancer research advocate Glenn Sykes talk with study chair Dr. Raquibul Hannan about this study for patients with slow-progressing cancer
September 26, 2024 September 26, 2024Categories Trial ResultsTrial Results: How one patient’s role in an ECOG-ACRIN study for acute lymphocytic leukemia brought a cancer-free diagnosis and FDA approvalAdding immunotherapy to standard chemotherapy keeps most patients with B-cell acute lymphoblastic leukemia in remission and improves their survival